-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AOgZifr/gGYoc2QNL+37g7UgQQhGJWGu9VQ1LXkpdHrv3RN1Oq1clonYXY59PY1q MJDjalavcbjBY6evzkaVwg== 0001209191-05-065747.txt : 20051228 0001209191-05-065747.hdr.sgml : 20051228 20051228172415 ACCESSION NUMBER: 0001209191-05-065747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051223 FILED AS OF DATE: 20051228 DATE AS OF CHANGE: 20051228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MURRAY A CENTRAL INDEX KEY: 0001226435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 051289529 BUSINESS ADDRESS: STREET 1: REGENERON PHARMACEUTICALS INC STREET 2: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143457491 4 1 bny16043_bny1mag.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-12-23 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226435 GOLDBERG MURRAY A 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591 0 1 0 0 SVP Fin & Admin, CFO, & Treas Common Stock 2005-12-23 4 M 1 1000 12.750 A 37516 D Common Stock 2005-12-23 4 S 1 1000 12.990 D 36516 D Common Stock 2005-12-23 4 M 1 1000 12.750 A 37516 D Common Stock 2005-12-23 4 S 1 1000 13.000 D 36516 D Common Stock 2005-12-23 4 M 1 1000 12.750 A 37516 D Common Stock 2005-12-23 4 S 1 1000 13.050 D 36516 D Common Stock 2005-12-23 4 M 1 100 12.750 A 36616 D Common Stock 2005-12-23 4 S 1 100 13.080 D 36516 D Common Stock 2005-12-23 4 M 1 700 12.750 A 37216 D Common Stock 2005-12-23 4 S 1 700 13.090 D 36516 D Common Stock 2005-12-23 4 M 1 4200 12.750 A 40716 D Common Stock 2005-12-23 4 S 1 4200 13.100 D 36516 D Common Stock 2005-12-23 4 M 1 1804 12.750 A 38320 D Common Stock 2005-12-23 4 S 1 1804 13.110 D 36516 D Common Stock 2005-12-23 4 M 1 1100 12.750 A 37616 D Common Stock 2005-12-23 4 S 1 1100 13.120 D 36516 D Common Stock 2005-12-23 4 M 1 246 12.750 A 36762 D Common Stock 2005-12-23 4 S 1 246 13.130 D 36516 D Common Stock 2005-12-23 4 M 1 1000 12.750 A 37516 D Common Stock 2005-12-23 4 S 1 1000 13.160 D 36516 D Common Stock 2005-12-23 4 M 1 17850 12.750 A 54366 D Common Stock 2005-12-23 4 F 1 17098 13.310 D 37268 D Common Stock 2005-12-23 4 F 1 260 13.310 D 37008 D Common Stock 2005-12-27 4 S 1 492 14.94 D 36516 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1000 0.00 D 2006-01-02 Common Stock 1000 11150 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1000 0.00 D 2006-01-02 Common Stock 1000 10150 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1000 0.00 D 2006-01-02 Common Stock 1000 9150 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 100 0.00 D 2006-01-02 Common Stock 100 9050 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 700 0.00 D 2006-01-02 Common Stock 700 8350 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 4200 0.00 D 2006-01-02 Common Stock 4200 4150 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1804 0.00 D 2006-01-02 Common Stock 1804 2346 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1100 0.00 D 2006-01-02 Common Stock 1100 1246 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 246 0.00 D 2006-01-02 Common Stock 246 1000 D Incentive Stock Option (right to buy) 12.750 2005-12-23 4 M 1 1000 0.00 D 2006-01-02 Common Stock 1000 0 D Non-Qualified Stock Option (right to buy) 12.750 2005-12-23 4 M 1 17850 0.00 D 2006-01-02 Common Stock 17850 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. By: /s/ **Stuart Kolinski For: /s/ **Murray A. Goldberg 2005-12-28 EX-24 2 y16043ex24.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Leonard Schleifer, , Beverly Dubs, Stuart Kolinski, Murray Goldberg, and Douglas McCorkle signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned in the undersigned's capacity as a director of Regeneron Pharmaceuticals, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-act on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of September, 2005. **/s/Murray A. Goldberg ----------------------- Signature Murray A. Goldberg ------------------ Print Name Page 1 -----END PRIVACY-ENHANCED MESSAGE-----